anonymous
Guest
anonymous
Guest
talking about patients, profits, payers, I think y’all need to step back.
The forces of the last 5+ years have already shown us the US pharma market is overblown.
2 reps, 3, Es, Ds Hs whatever ... it all points to are we really bringing value.
Covid cut the lunch cord. We’re not critical to the practice, payers have more leverage each day and profits suffer.
Don’t kid yourself, it’s not sustainable.
It’s time to change industries before you’ve got 20+ years in pharma, are in you 50s, are a while male and a ‘restructuring’ takes place.
A three-legged turtle has a better chance of surviving in the Serengeti.
The forces of the last 5+ years have already shown us the US pharma market is overblown.
2 reps, 3, Es, Ds Hs whatever ... it all points to are we really bringing value.
Covid cut the lunch cord. We’re not critical to the practice, payers have more leverage each day and profits suffer.
Don’t kid yourself, it’s not sustainable.
It’s time to change industries before you’ve got 20+ years in pharma, are in you 50s, are a while male and a ‘restructuring’ takes place.
A three-legged turtle has a better chance of surviving in the Serengeti.